OD-doxy-PNV-COVID-19 Old Drug ' DOXY ' for Prevention of New Virus ' COVID-19 '
OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
NCT ID: NCT04584567 Phase: PHASE3 Status: COMPLETED Enrollment: 194 Completion: 2021-11-01
Conditions
Covid19
Interventions
Doxycyclin
Summary
Given the urgency of having guidelines for the management of COVID-19 in the current epidemic context and the lack of specific pharmacological treatment, Military Health recommends the launch of a multicenter, randomized, double-blind, interventional clinical trial.
The aim of this study is to evaluate the efficacy of a combination of two treatments, low-dose doxcycline (100 mg/day) and Zinc (15 mg/day) (dietary supplement) in the primary prevention of COVID-19 infection in health care professionals in Tunisia compared to two control groups.
Primary Outcome
decreasing the number of cases infected with covid 19